{"id":"https://openalex.org/W7203755899","doi":"https://doi.org/10.1016/j.jacadv.2026.103107","title":"Lipid-Lowering Therapy Preferences in the LISTEN-LDL-US Study","display_name":"Lipid-Lowering Therapy Preferences in the LISTEN-LDL-US Study","publication_year":2026,"publication_date":"2026-08-19","ids":{"openalex":"https://openalex.org/W7203755899","doi":"https://doi.org/10.1016/j.jacadv.2026.103107","pmid":"https://pubmed.ncbi.nlm.nih.gov/42617488","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13521076"},"language":"en","primary_location":{"id":"doi:10.1016/j.jacadv.2026.103107","doi":"https://doi.org/10.1016/j.jacadv.2026.103107","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jacadv.2026.103107","pdf_url":"https://www.jacc.org/doi/pdf/10.1016/j.jacadv.2026.103107?download=true","source":{"id":"https://openalex.org/S4220651314","display_name":"JACC Advances","issn_l":"2772-963X","issn":["2772-963X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","doyens","jufo-1","ki-jl-1","norway-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JACC: Advances","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.jacc.org/doi/pdf/10.1016/j.jacadv.2026.103107?download=true","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5046257512","display_name":"Michael G. Nanna","orcid":"https://orcid.org/0000-0001-5745-1636","observed_orcids":["https://orcid.org/0000-0001-5745-1636"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Michael G. Nanna","raw_affiliation_strings":["Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, Connecticut, USA. Electronic address: michael.nanna@yale.edu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, Connecticut, USA. Electronic address: michael.nanna@yale.edu","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034577940","display_name":"Alejandro Victores","orcid":"https://orcid.org/0000-0003-4988-5594","observed_orcids":["https://orcid.org/0000-0003-4988-5594"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alejandro Victores","raw_affiliation_strings":["Merck & Co, Inc, Rahway, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co, Inc, Rahway, New Jersey, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5130791147","display_name":"Kyle Snyder","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kyle Snyder","raw_affiliation_strings":["Merck & Co, Inc, Rahway, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co, Inc, Rahway, New Jersey, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062912167","display_name":"Lori D. Bash","orcid":"https://orcid.org/0000-0002-6036-2498","observed_orcids":["https://orcid.org/0000-0002-6036-2498"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lori D. Bash","raw_affiliation_strings":["Merck & Co, Inc, Rahway, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co, Inc, Rahway, New Jersey, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060734606","display_name":"Kathryn L. Krupsky","orcid":"https://orcid.org/0000-0001-8793-6861","observed_orcids":["https://orcid.org/0000-0001-8793-6861"]},"institutions":[{"id":"https://openalex.org/I1342911587","display_name":"Oracle (United States)","ror":"https://ror.org/006c77m33","country_code":"US","type":"company","lineage":["https://openalex.org/I1342911587"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kathryn Krupsky","raw_affiliation_strings":["Oracle Life Sciences, Austin, Texas, USA"],"raw_orcid":"https://orcid.org/0000-0001-8793-6861","affiliations":[{"raw_affiliation_string":"Oracle Life Sciences, Austin, Texas, USA","institution_ids":["https://openalex.org/I1342911587"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051366518","display_name":"Elizabeth McCaig","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1342911587","display_name":"Oracle (United States)","ror":"https://ror.org/006c77m33","country_code":"US","type":"company","lineage":["https://openalex.org/I1342911587"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth McCaig","raw_affiliation_strings":["Oracle Life Sciences, Austin, Texas, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oracle Life Sciences, Austin, Texas, USA","institution_ids":["https://openalex.org/I1342911587"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041948879","display_name":"Kristen King-Concialdi","orcid":"https://orcid.org/0000-0002-9612-3595","observed_orcids":["https://orcid.org/0000-0002-9612-3595"]},"institutions":[{"id":"https://openalex.org/I1342911587","display_name":"Oracle (United States)","ror":"https://ror.org/006c77m33","country_code":"US","type":"company","lineage":["https://openalex.org/I1342911587"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kristen King-Concialdi","raw_affiliation_strings":["Oracle Life Sciences, Austin, Texas, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oracle Life Sciences, Austin, Texas, USA","institution_ids":["https://openalex.org/I1342911587"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5135587806","display_name":"Kathleen Beusterien","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1342911587","display_name":"Oracle (United States)","ror":"https://ror.org/006c77m33","country_code":"US","type":"company","lineage":["https://openalex.org/I1342911587"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kathleen Beusterien","raw_affiliation_strings":["Oracle Life Sciences, Austin, Texas, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oracle Life Sciences, Austin, Texas, USA","institution_ids":["https://openalex.org/I1342911587"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036812763","display_name":"Jacob Matta","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1342911587","display_name":"Oracle (United States)","ror":"https://ror.org/006c77m33","country_code":"US","type":"company","lineage":["https://openalex.org/I1342911587"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jacob Matta","raw_affiliation_strings":["Oracle Life Sciences, Austin, Texas, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oracle Life Sciences, Austin, Texas, USA","institution_ids":["https://openalex.org/I1342911587"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070395491","display_name":"Matthew W. Brault","orcid":"https://orcid.org/0000-0001-8248-1714","observed_orcids":["https://orcid.org/0000-0001-8248-1714"]},"institutions":[{"id":"https://openalex.org/I1342911587","display_name":"Oracle (United States)","ror":"https://ror.org/006c77m33","country_code":"US","type":"company","lineage":["https://openalex.org/I1342911587"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew W. Brault","raw_affiliation_strings":["Oracle Life Sciences, Austin, Texas, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oracle Life Sciences, Austin, Texas, USA","institution_ids":["https://openalex.org/I1342911587"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5039835286","display_name":"Payal Kohli","orcid":"https://orcid.org/0000-0002-1049-5233","observed_orcids":["https://orcid.org/0000-0002-1049-5233"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Payal Kohli","raw_affiliation_strings":["Cardiology Division, Johns Hopkins University, Baltimore, Maryland, USA; Cardiology Division, Duke University, Durham, North Carolina, USA; Cherry Creek Heart, Aurora, Colorado, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardiology Division, Johns Hopkins University, Baltimore, Maryland, USA; Cardiology Division, Duke University, Durham, North Carolina, USA; Cherry Creek Heart, Aurora, Colorado, USA","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I170897317"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5046257512"],"corresponding_institution_ids":["https://openalex.org/I32971472"],"apc_list":{"value":2936,"currency":"USD","value_usd":2936},"apc_paid":{"value":2936,"currency":"USD","value_usd":2936},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.62970586,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"5","issue":"9","first_page":"103107","last_page":"103107"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10841","display_name":"Economic and Environmental Valuation","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11620","display_name":"Medication Adherence and Compliance","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2714","display_name":"Family Practice"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lipid-lowering-therapy","display_name":"lipid-lowering therapy","score":0.9890000224113464},{"id":"https://openalex.org/keywords/patient-preferences","display_name":"patient preferences","score":0.9350000023841858},{"id":"https://openalex.org/keywords/ldl-cholesterol","display_name":"LDL cholesterol","score":0.859000027179718},{"id":"https://openalex.org/keywords/atherosclerotic-cardiovascular-disease","display_name":"atherosclerotic cardiovascular disease","score":0.9409999847412109},{"id":"https://openalex.org/keywords/shared-decision-making","display_name":"shared decision-making","score":0.8550000190734863},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.7870000004768372},{"id":"https://openalex.org/keywords/mode-of-administration","display_name":"mode of administration","score":0.9599999785423279},{"id":"https://openalex.org/keywords/cardiovascular-risk-reduction","display_name":"cardiovascular risk reduction","score":0.6669999957084656},{"id":"https://openalex.org/keywords/discrete-choice-experiment","display_name":"discrete choice experiment","score":0.5740000009536743},{"id":"https://openalex.org/keywords/preference-weights","display_name":"preference weights","score":0.41999998688697815}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8227999806404114},{"id":"https://openalex.org/C81603835","wikidata":"https://www.wikidata.org/wiki/Q3457430","display_name":"Pill","level":2,"score":0.7264999747276306},{"id":"https://openalex.org/C2781249084","wikidata":"https://www.wikidata.org/wiki/Q908656","display_name":"Preference","level":2,"score":0.5960000157356262},{"id":"https://openalex.org/C2780645631","wikidata":"https://www.wikidata.org/wiki/Q671554","display_name":"Stroke (engine)","level":2,"score":0.45320001244544983},{"id":"https://openalex.org/C64341305","wikidata":"https://www.wikidata.org/wiki/Q4919225","display_name":"Bivariate analysis","level":2,"score":0.41029998660087585},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4056999981403351},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.3776000142097473},{"id":"https://openalex.org/C199163554","wikidata":"https://www.wikidata.org/wiki/Q1681619","display_name":"Univariate","level":3,"score":0.367900013923645},{"id":"https://openalex.org/C3018553135","wikidata":"https://www.wikidata.org/wiki/Q67004728","display_name":"Medication adherence","level":2,"score":0.36570000648498535},{"id":"https://openalex.org/C50440223","wikidata":"https://www.wikidata.org/wiki/Q1475848","display_name":"Risk factor","level":2,"score":0.36010000109672546},{"id":"https://openalex.org/C23131810","wikidata":"https://www.wikidata.org/wiki/Q818574","display_name":"Observational study","level":2,"score":0.34769999980926514},{"id":"https://openalex.org/C2780074459","wikidata":"https://www.wikidata.org/wiki/Q389735","display_name":"Heart disease","level":2,"score":0.33219999074935913},{"id":"https://openalex.org/C82789193","wikidata":"https://www.wikidata.org/wiki/Q2142611","display_name":"Relative risk","level":3,"score":0.3059000074863434},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.3028999865055084},{"id":"https://openalex.org/C38180746","wikidata":"https://www.wikidata.org/wiki/Q1952580","display_name":"Multivariate analysis","level":2,"score":0.2833000123500824},{"id":"https://openalex.org/C2779464278","wikidata":"https://www.wikidata.org/wiki/Q7317735","display_name":"Revascularization","level":3,"score":0.2759999930858612},{"id":"https://openalex.org/C2909478654","wikidata":"https://www.wikidata.org/wiki/Q844935","display_name":"Atherosclerotic cardiovascular disease","level":3,"score":0.2734000086784363},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2720000147819519}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1016/j.jacadv.2026.103107","doi":"https://doi.org/10.1016/j.jacadv.2026.103107","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jacadv.2026.103107","pdf_url":"https://www.jacc.org/doi/pdf/10.1016/j.jacadv.2026.103107?download=true","source":{"id":"https://openalex.org/S4220651314","display_name":"JACC Advances","issn_l":"2772-963X","issn":["2772-963X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","doyens","jufo-1","ki-jl-1","norway-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JACC: Advances","raw_type":"journal-article"},{"id":"pmid:42617488","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42617488","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JACC. Advances","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13521076","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13521076/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JACC Adv","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:62c7f57350d5467cbfe627ab82705538","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/62c7f57350d5467cbfe627ab82705538","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"JACC: Advances, Vol 5, Iss 9, Pp 103107- (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.jacadv.2026.103107","doi":"https://doi.org/10.1016/j.jacadv.2026.103107","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jacadv.2026.103107","pdf_url":"https://www.jacc.org/doi/pdf/10.1016/j.jacadv.2026.103107?download=true","source":{"id":"https://openalex.org/S4220651314","display_name":"JACC Advances","issn_l":"2772-963X","issn":["2772-963X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","doyens","jufo-1","ki-jl-1","norway-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JACC: Advances","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[{"id":"https://openalex.org/G6881567127","display_name":null,"funder_award_id":"P30AG021342","funder_id":"https://openalex.org/F4320308380","funder_display_name":"Yale University"},{"id":"https://openalex.org/G9000898069","display_name":"Estimating the treatment effect of cardiovascular medications to modify the risk for future cognitive decline in older adults","funder_award_id":"K76AG088428","funder_id":"https://openalex.org/F4320337337","funder_display_name":"National Institute on Aging"},{"id":"https://openalex.org/G9000916443","display_name":"Claude D. Pepper Older Americans Independence Center at Yale","funder_award_id":"P30AG021342","funder_id":"https://openalex.org/F4320337337","funder_display_name":"National Institute on Aging"}],"funders":[{"id":"https://openalex.org/F4320308380","display_name":"Yale University","ror":"https://ror.org/03v76x132"},{"id":"https://openalex.org/F4320322436","display_name":"Novo Nordisk","ror":"https://ror.org/0435rc536"},{"id":"https://openalex.org/F4320337337","display_name":"National Institute on Aging","ror":"https://ror.org/049v75w11"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7203755899.pdf","grobid_xml":"https://content.openalex.org/works/W7203755899.grobid-xml"},"referenced_works_count":38,"referenced_works":["https://openalex.org/W2121619367","https://openalex.org/W2122707212","https://openalex.org/W2183544076","https://openalex.org/W2367707061","https://openalex.org/W2513422586","https://openalex.org/W2740472173","https://openalex.org/W2807844095","https://openalex.org/W2904210113","https://openalex.org/W2905424513","https://openalex.org/W2908382599","https://openalex.org/W2968097947","https://openalex.org/W2971701011","https://openalex.org/W2984766121","https://openalex.org/W3022919671","https://openalex.org/W3035033052","https://openalex.org/W3102490672","https://openalex.org/W3119991037","https://openalex.org/W3129818723","https://openalex.org/W3141754952","https://openalex.org/W3170272938","https://openalex.org/W4220771406","https://openalex.org/W4283817584","https://openalex.org/W4293253252","https://openalex.org/W4313471811","https://openalex.org/W4378952150","https://openalex.org/W4385798525","https://openalex.org/W4386123426","https://openalex.org/W4388534528","https://openalex.org/W4389827793","https://openalex.org/W4391138872","https://openalex.org/W4392906909","https://openalex.org/W4393065697","https://openalex.org/W4394615375","https://openalex.org/W4405195907","https://openalex.org/W4406845258","https://openalex.org/W4409445578","https://openalex.org/W4410586503","https://openalex.org/W4412192379"],"related_works":["https://openalex.org/W4414418419","https://openalex.org/W4390124962","https://openalex.org/W4412788109","https://openalex.org/W7165036829","https://openalex.org/W4380794625","https://openalex.org/W4401421032","https://openalex.org/W4394615375","https://openalex.org/W4412192379","https://openalex.org/W2767074269","https://openalex.org/W4405195907"],"abstract_inverted_index":{"BACKGROUND:":[0],"Low-density":[1],"lipoprotein":[2],"cholesterol":[3],"(LDL-C),":[4],"among":[5],"other":[6],"lipids,":[7],"is":[8,25,229],"a":[9,64,69,183,187,230],"strong":[10],"causal":[11],"and":[12,27,50,54,63,76,100,110,116,142,152,220,245],"modifiable":[13],"risk":[14,210,218],"factor":[15],"for":[16,43,66],"atherosclerotic":[17],"cardiovascular":[18,217],"disease":[19],"(ASCVD).":[20],"However,":[21],"lipid-lowering":[22],"therapy":[23],"(LLT)":[24],"underutilized":[26],"many":[28],"patients":[29],"do":[30],"not":[31],"reach":[32],"LDL-C":[33,62,87],"goals.":[34],"OBJECTIVES:":[35],"This":[36],"study":[37],"aimed":[38],"to":[39,46],"evaluate":[40],"patient":[41,237],"preferences":[42,83,238],"LLT":[44,67,234],"attributes":[45],"inform":[47],"shared":[48,240],"decision-making":[49,241],"improve":[51,243],"treatment":[52,74,154],"adoption":[53],"adherence.":[55],"METHODS:":[56],"Adults":[57],"\u226540":[58],"years":[59],"with":[60,213],"elevated":[61],"recommendation":[65],"completed":[68],"cross-sectional,":[70],"web-based":[71],"survey":[72],"assessing":[73],"experiences":[75],"preferences.":[77,235],"A":[78,171],"discrete":[79],"choice":[80],"experiment":[81],"elicited":[82],"across":[84],"7":[85],"attributes:":[86],"reduction,":[88],"stroke":[89],"risk,":[90,93,95],"heart":[91],"attack":[92],"revascularization":[94],"new-onset":[96],"diabetes,":[97],"musculoskeletal":[98],"pain,":[99],"regimen/mode":[101],"of":[102,160,227,233,247],"administration.":[103],"Survey":[104],"responses":[105],"were":[106,119,140,144,201],"analyzed":[107],"using":[108,121],"univariate":[109],"bivariate":[111],"methods.":[112],"Preference":[113],"weights":[114],"(PW)":[115],"relative":[117],"importance":[118,168],"estimated":[120],"hierarchical":[122],"Bayesian":[123],"modeling.":[124],"RESULTS:":[125],"Among":[126],"508":[127],"participants":[128],"(mean":[129],"age:":[130],"62.8":[131],"\u00b1":[132],"11.4":[133],"years),":[134],"49.0%":[135],"had":[136],"prior":[137],"ASCVD,":[138],"55.3%":[139],"female,":[141],"43.9%":[143],"current":[145],"or":[146],"former":[147],"smokers.":[148],"Participants":[149],"prioritized":[150],"immediate":[151],"tangible":[153],"features":[155],"over":[156],"long-term":[157],"benefits.":[158],"Mode":[159,226],"administration":[161,228],"was":[162,175,211],"the":[163],"most":[164,176],"influential":[165],"attribute":[166],"(relative":[167],"=":[169,179,194,205],"25.9).":[170],"once-daily":[172],"oral":[173,189],"pill":[174,185,190],"preferred":[177,203],"(PW":[178,193,204],"1.75),":[180],"followed":[181],"by":[182],"daily":[184],"plus":[186],"second":[188],"before":[191],"breakfast":[192],"0.17),":[195],"whereas":[196],"regimens":[197],"including":[198],"biweekly":[199],"injections":[200],"least":[202],"-1.13).":[206],"Higher":[207],"perceived":[208],"ASCVD":[209],"associated":[212],"greater":[214],"emphasis":[215,222],"on":[216,223],"reduction":[219],"less":[221],"regimen.":[224],"CONCLUSIONS:":[225],"key":[231],"driver":[232],"Incorporating":[236],"into":[239],"may":[242],"adherence":[244],"implementation":[246],"guideline-directed":[248],"therapy.":[249]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2026-08-20T00:00:00"}